RANA LEE: Open Payments
NPI 1154090645 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 5 payments from 5 companies in 2025. Trend: 2023 $201 · 2024 $215 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| GlaxoSmithKline, LLC. | 1 | $83 |
| Lilly USA, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: FARXIGA, ZEPBOUND, LEQVIO, OTEZLA.
Industry payments across CA — which companies pay providers there.
